Clinical Trials Logo

Dental Pulp Exposure clinical trials

View clinical trials related to Dental Pulp Exposure.

Filter by:

NCT ID: NCT03631511 Completed - Clinical trials for Dental Pulp Exposure

Histological Evaluation of Hard Tissue Formation After Direct Pulp Capping With RetroMTA

RetroMTA
Start date: April 3, 2016
Phase: N/A
Study type: Interventional

This study presents a clinical and histological evaluation of human pulp tissue responses after direct capping using RetroMTA. Seven teeth were subjected to pulp exposure, direct capping with RetroMTA, and restoration with a composite resin. Seven months later, the teeth were clinically and radiographically evaluated. The teeth were then extracted and subjected to histological processing and evaluation.

NCT ID: NCT03490422 Completed - Pulpitis Clinical Trials

Pulpotomy in Carious Permanent Mature Teeth: Pulp Survival and Risk Factors

Start date: October 2013
Phase: N/A
Study type: Interventional

This Trial evaluated the extent of pulp survival following pulpotomy in the permanent tooth pulp exposed by caries and identify potential risk factors for pulpal complications.

NCT ID: NCT02789423 Completed - Clinical trials for Dental Pulp Exposure

Clinical & Radiographical Evaluation of the Effect of Dycal & Biodentine in DPC in Primary Teeth

Start date: June 2013
Phase: N/A
Study type: Interventional

The purpose of this study was clinical and radiographical evaluation of the effect of calcium hydroxide cement (Dycal) and calcium silicate cement (Biodentine) in direct pulp capping in primary teeth.

NCT ID: NCT02492841 Completed - Caries Clinical Trials

Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth

Start date: April 2014
Phase: Phase 2/Phase 3
Study type: Interventional

Background: Dental caries is considered an oral health problem worldwide. In Chile the last national epidemiological study (2007) showed a national prevalence of dental caries in children 6 years (70.3%) and 12 (62.5%). Direct pulp capping is a preventive dental therapy, keeps the vitality of the tooth using some inductive materials mineralized tissue formation. Objective: The main objective of this study is to evaluate the effectiveness of two innovative direct pulp capping materials; Biodentine compared MTA and calcium hydroxide in the maintenance of pulp vitality in teeth permanent molars.

NCT ID: NCT02487329 Completed - Clinical trials for Dental Pulp Exposure

The Effect of Laser Combined With Pulp-capping Agents on Direct Pulp Capping

Start date: January 2015
Phase: N/A
Study type: Interventional

The purpose of this randomized clinical study was to evaluate the efficiency of Er,Cr:YSGG laser irradiation combined with a resin based tricalcium silicate material and calcium hydroxide (CH) in direct pulp capping for 3 months follow-up period.Sixty permanent vital teeth without symptoms and radiographic changes were randomly assigned to 4 groups (n=15): Gr 1: The exposed area was sealed with CH paste, Gr 2: The treated area was sealed with CH paste following Er,Cr:YSGG laser irradiation at an energy level of 0,5 W without water and 45% air, Gr 3: Resin based tricalcium silicate material (TheraCal LC) was applied directly to the exposed pulp, Gr 4: TheraCal LC was applied following irradiation with Er,Cr:YSGG laser.

NCT ID: NCT02019563 Completed - Dental Caries Clinical Trials

MTA/FS Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial

MTA/FS
Start date: September 2010
Phase: Phase 2
Study type: Interventional

To compare radiographic and clinical outcomes and survival of mineral trioxide aggregate/ferric sulfate (MTA/FS) pulpotomy and root canal therapy (RCT) in carious vital primary maxillary incisors.

NCT ID: NCT01468480 Completed - Clinical trials for Dental Pulp Exposure

Human Pulpal Response After Pulp Capping With Four Different Agents

Start date: June 2010
Phase: Phase 2/Phase 3
Study type: Interventional

Application of four different pulp capping methods on human sound premolars after intentional exposure of the buccal pulp horn through a class one occlusal cavity.

NCT ID: NCT00812877 Completed - Clinical trials for Dental Pulp Exposure

Pulp Capping With Two Different Agents

MTA
Start date: May 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if MTA or calcium hydroxide are more effective as pulp capping agents

NCT ID: NCT00187850 Completed - Clinical trials for Dental Pulp Exposure

The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy

Start date: February 2005
Phase: N/A
Study type: Interventional

CAP-2 Trial Background: This trial is being done in conjunction with an ongoing clinical trial investigating stepwise excavation versus final excavation on deep caries lesions (The CAP-1 trial). The investigators lack systematic knowledge concerning the treatment of the exposed pulp and whether the capping of a pulp represents the same outcome as the partial removal of an additional 1-1.5 mm of the pulp tissue (partial pulpotomy). Aim: The aim of the CAP-2 trial is in a randomised clinical trial to investigate the effect of direct pulp capping versus partial pulpotomy in patients who, from the beginning, have received either a final excavation or a stepwise excavation and where this intervention has led to the exposure of a vital pulp and/or the patient has not gained relief from tooth pain after excavation and placement of a temporary restoration. Patients: Patients include consecutive patients with deep caries who have been participating in the CAP-1 trial, where the pulp exposure to a bleeding pulp is present and/or pain relief has not been obtained. Design: The CAP-2 trial is a randomised patient- and observer-blinded multicenter trial, with two parallel intervention groups. Patients who fulfill the inclusion criteria will be centrally bloc-randomised in the Copenhagen Trial Unit, Copenhagen DK, and stratified by age and pain. The allocation ratio is 1:1. The Interventions and Products: Patients are allocated for direct pulp capping or partial pulpotomy. The patients will not be informed about the results of the randomisation, i.e. the type of intervention. In both groups the patient receives a calcium hydroxide seal covering the exposure and a glass ionomer restoration. The final resin restoration is placed following 4 weeks.